
0:00
4:34
Rachel E. Sanborn, MD, presents the journey of a patient diagnosed with atypical carcinoid with brain metastases who benefited from the detection of a KIF5B-RET fusion by comprehensive genomic profiling. Rachel E. Sanborn, MD is the medical director of the Thoracic Oncology and Phase I Clinical Trials Programs at the Earle A. Chiles Research Institute at Providence Cancer Institute.
Flere episoder fra "Illumina Genomics Podcast"



Gå ikke glip af nogen episoder af “Illumina Genomics Podcast” - abonnér på podcasten med gratisapp GetPodcast.








